Գերմանիա -
գերմաներեն -
BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)
rifater
sanofi-aventis deutschland gmbh (8030868) - isoniazid; rifampicin; pyrazinamid - überzogene tablette - isoniazid (00155) 50 milligramm; rifampicin (02599) 120 milligramm; pyrazinamid (03555) 300 milligramm
Շվեյցարիա -
գերմաներեն -
Swissmedic (Swiss Agency for Therapeutic Products)
rifater überzogene tabletten
sanofi-aventis (suisse) sa - rifampicinum, isoniazidum, pyrazinamidum - überzogene tabletten - rifampicinum 120 mg, isoniazidum 50 mg, pyrazinamidum 300 mg, natrii laurilsulfas, calcii stearas, saccharum 105 mg, carmellosum natricum, povidonum k 30, magnesii subcarbonas levis, kaolinum ponderosum, acaciae gummi, talcum, silica colloidalis anhydrica, aluminii oxidum hydricum, e 171, e 172 (rubrum) pro compresso obducto corresp. natrium 2.83 mg. - tuberculose - synthetika
Ավստրիա -
գերմաներեն -
AGES (Agentur für Gesundheit und Ernährungssicherheit)
rifater - dragees
sanofi-aventis gmbh - pyrazinamid,isoniazid,rifampicin - combinations of drugs for
Շվեյցարիա -
գերմաներեն -
Swissmedic (Swiss Agency for Therapeutic Products)
rifinah überzogene tabletten
sanofi-aventis (suisse) sa - rifampicinum, isoniazidum - überzogene tabletten - rifampicinum 150 mg, isoniazidum 100 mg, natrii laurilsulfas, calcii stearas, carmellosum natricum, cellulosum microcristallinum, magnesii stearas, pellicule: gelatina, magnesii subcarbonas levis, acaciae gummi, povidonum k 30, saccharum 110 mg, talcum, kaolinum ponderosum, silica colloidalis anhydrica, e 127, e 171 pro compresso obducto corresp. natrium 2.28 mg. - tuberculose - synthetika
Եվրոպական Միություն -
գերմաներեն -
EMA (European Medicines Agency)
pemetrexed baxter
baxter holding b.v. - pemetrexed disodium heptahydrate - carcinoma, non-small-cell lung; mesothelioma - antineoplastische mittel - malignant pleural mesotheliomapemetrexed baxter in combination with cisplatin is indicated for the treatment of chemotherapy naïve patients with unresectable malignant pleural mesothelioma. non-small cell lung cancerpemetrexed baxter in combination with cisplatin is indicated for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see section 5. pemetrexed baxter is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy (see section 5. pemetrexed baxter is indicated as monotherapy for the second line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see section 5.
Գերմանիա -
գերմաներեն -
BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)
daptomycin baxter 500 mg pulver zur herstellung einer injektions-/infusionslösung
baxter holding b.v. (8182259) - pulver zur herstellung einer injektions- /infusionslösung - 500 mg